Ticker
ANABCompany Name
ANAPTYSBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 44.3M | 1.25 | $ 35.53M |
3/31/2025 | $ 98.64M | 2.24 | $ 44.04M |
12/31/2024 | $ 123.08M | 2.71 | $ 45.43M |
9/30/2024 | $ 191.58M | 4.37 | $ 43.88M |
6/30/2024 | $ 71.82M | 1.78 | $ 40.42M |
3/31/2024 | $ 53.7M | 1.66 | $ 32.3M |
12/31/2023 | $ 35.97M | 0.96 | $ 37.44M |
9/30/2023 | $ 26.3M | 0.67 | $ 39.18M |
6/30/2023 | $ 35.21M | 0.85 | $ 41.63M |
3/31/2023 | $ 94.56M | 2.64 | $ 35.8M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for ANAPTYSBIO INC is calculated as follows: CashnEq [ $ 209.21M ] / LiabilitesC [ $ 24.47M ]
(=) Cash Ratio [ 8.55 ]
Minimum
Sep 30, 2023
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |